Keywords: appointment, king, pharmaceuticals, michael, jolly, joined, executive

Appointment at King Pharmaceuticals

Article | 16 March 2000

Print This

Michael Jolly has joined King Pharmaceuticals as executive vicepresident of clinical R&D. Dr Jolly comes from Quintiles Inc.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in